О. В. Бугрова

1.2k citations
18 papers · 930 · 1 hit paper · h-index 8

Impact in

  • Rheumatology top 2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Nephrology top 10%
    • Renal Diseases and Glomerulopathies

Papers in

  • Rheumatology 14
    • Spondyloarthritis Studies and Treatments 9
    • Rheumatoid Arthritis Research and Therapies 7
    • Systemic Lupus Erythematosus Research 2
  • Anatomy 3
    • Medical and Biological Sciences 3
Co-authors
Andrey P. Rebrov (8 shared papers)Tatiana V Korotaeva (7 shared papers)Olga B. Nesmeyanova (7 shared papers)Tatiana A. Raskina (7 shared papers)Ш. Ф. Эрдес (7 shared papers)Irina Petrovna Nikishina (6 shared papers)Olga Nikolaevna Ivanova (6 shared papers)Alexander Smirnov (6 shared papers)
Journals
Journal of the American Heart Association (1 paper)Kidney International (1 paper)The Lancet (1 paper)Terapevticheskii arkhiv (1 paper)Rheumatology Science and Practice (9 papers)
Partner nations
RussiaUnited KingdomUnited States

In The Last Decade

О. В. Бугрова

14 papers receiving 866 citations

О. В. Бугрова's Hit Papers

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial 2017 · 412 citations
4120+3+6Years since publication100200300400
What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

  1. 2017 The Lancet

Peers

О. В. Бугрова
Comparison fields: 5 of 70
  • Rheumatology 614
  • Nephrology 74
  • Hematology 101
  • Immunology 160
  • Cardiology and Cardiovascular Medicine 142
Replace S.C. Heslinga with:
S.C. Heslinga Netherlands
Alessia Morelli Italy
Etsuji Suehisa Japan
Emily Wai Lin Kun China
B. Boutière France
Deva Situnayake United Kingdom
JP Cosyns Belgium
Francesca Bartoli Italy
Shinobu Waga Japan
Alberto Alonso-Ruiz Spain
О. В. Бугрова relative to S.C. Heslinga Netherlands S.C. Heslinga's profile →
Citations per field
00.5×2×3.4×
S.C. Heslinga · 1×
Citations per year

Countries citing papers authored by О. В. Бугрова

Since Specialization
Citations

This map shows the geographic impact of О. В. Бугрова's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by О. В. Бугрова with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites О. В. Бугрова more than expected).

Fields of papers citing papers by О. В. Бугрова

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by О. В. Бугрова. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by О. В. Бугрова. The network helps show where О. В. Бугрова may publish in the future.

Co-authors

The 17 scholars most cited alongside О. В. Бугрова, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with О. В. Бугрова Line = papers co-authored together О. В. Бугрова links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
The Lancet ·Roy Fleischmann, Eduardo Mysler, Stephen Hall, Alan Kivitz, Robert J. Moots, Zhen Luo, Ryan DeMasi, Koshika Soma
Hit paper breakdown →		2017412
2
A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
Kidney International ·Brad H. Rovin, Neil Solomons, William F. Pendergraft, Mary Anne Dooley, James Alan Tumlin, Juanita Romero‐Díaz, Lidia Lysenko (Kozlovskaya, Sandra Navarra
2018227
3
Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Journal of the American Heart Association ·Sean D. Pokorney, Jonathan Paul Piccini, Susanna R. Stevens, Manesh R. Patel, Karen S. Pieper, Jonathan L. Halperin, Günter Breithardt, Daniel E. Singer
2016172
4
ON THE TERMINOLOGY OF SPONDYLOARTHRITIS
Rheumatology Science and Practice ·Ш. Ф. Эрдес, V. V. Badokin, A. G. Bochkova, О. В. Бугрова, Inna Zurabievna Gaidukova, Alla Aleksandrovna Godzenko, A. A. Dubikov, Tatiana Dubinina
201531
5
GUIDELINES FOR THE ASSESSMENT OF DISEASE ACTIVITY AND FUNCTIONAL STATUS IN PATIENTS WITH ANKYLOSING SPONDYLITIS IN CLINICAL PRACTICE
Rheumatology Science and Practice ·Т. В. Дубинина, Inna Zurabievna Gaidukova, Alla Aleksandrovna Godzenko, Svetlana Lapshina, Andrey P. Rebrov, O. A. Rumyantseva, V. V. Badokin, A. G. Bochkova
201722
6
THE EUROPEAN SOCIETY FOR CLINICAL AND ECONOMIC ASPECTS OF OSTEOPOROSIS AND OSTEOARTHRITIS (ESCEO) ALGORITHM FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS IS APPLICABLE TO RUSSIAN CLINICAL PRACTICE: A CONSENSUS STATEMENT OF LEADING RUSSIAN AND ESCEO OSTEOARTHRITIS EXPERTS
Rheumatology Science and Practice ·Lev Nikolayevich Denisov, Е. С. Цветкова, George Sh. Golubev, О. В. Бугрова, И. С. Дыдыкина, А. И. Дубиков, L. V. Menshikova, Lyudmila K. Peshekhonova
201718
7
Spondyloarthritis: modern terminology and definitions
Terapevticheskii arkhiv ·Ш. Ф. Эрдес, Andrey P. Rebrov, Т. В. Дубинина, Vladimir Vasil'evich Badokin, Anna Georgiyevna Bochkova, О. В. Бугрова, Inna Z. Gaydukova, Alla Aleksandrovna Godzenko
201917
8
USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND BIOLOGICAL AGENTS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIDES. RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»
Rheumatology Science and Practice ·Inna Zurabievna Gaidukova, Andrey P. Rebrov, Svetlana Lapshina, Elvira Nikolayevna Otteva, Tatiana Dubinina, V. V. Badokin, A. G. Bochkova, О. В. Бугрова
201711
9
USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
Rheumatology Science and Practice ·Inna Zurabievna Gaidukova, Andrey P. Rebrov, Elvira Nikolayevna Otteva, V. V. Badokin, A. G. Bochkova, О. В. Бугрова, Alla Aleksandrovna Godzenko, A. A. Dubikov
20165
10
REMISSION IN AXIAL SPONDYLOARTHRITIS: DEFINITION AND EVALUATION TOOLS (RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»)
Rheumatology Science and Practice ·Inna Zurabievna Gaidukova, Andrey P. Rebrov, Tatiana V Korotaeva, Т. В. Дубинина, Elvira Nikolayevna Otteva, V. V. Badokin, Anna Georgiyevna Bochkova, О. В. Бугрова
20185
11
TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
Rheumatology Science and Practice ·Svetlana Lapshina, Т. В. Дубинина, V. V. Badokin, A. G. Bochkova, О. В. Бугрова, Inna Zurabievna Gaidukova, Alla Aleksandrovna Godzenko, A. A. Dubikov
20163
12
FEATURES OF AN INFECTIOUS ENDOCARDITIS IN INJECTION «SALT» ADDICTS
The Russian Archives of Internal Medicine ·М. В. Столбова, U. V. Liscova, N. E. Artemova, Р. И. Сайфутдинов, О. В. Бугрова
20173
13
SOME BONE METABOLIC PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
Rheumatology Science and Practice ·Svetlana Mikhailovna Antonova, О. В. Бугрова, И А Александрова, Н. А. Овчинникова
20101
14
OSOBENNOSTI METABOLIZMA KOSTNOY TKANI U BOL'NYKh ANKILOZIRUYuShchIM SPONDILOARTRITOM
Osteoporosis and Bone Diseases ·S A Yushina, О. В. Бугрова, Н. А. Овчинникова, И А Александрова
20111
15
BONE METABOLISM AND ITS REGULATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS
Rheumatology Science and Practice ·О. В. Бугрова, К. А. Нагорнова, N. E. Artemova
20161
16
Ankylosing spondylitis: diagnostic challenges and efficacy of upadacitinib
Sergey Valentinovich Moiseev, P. Novikov, Sergei V. Gulyaev, Ekaterina Kuznetsova, Tatiana Shevtsova, И. А. Шафиева, О. В. Бугрова
20211
17
Results of a non-interventional multicenter study of management of patients with non-radiological axial spondyloarthritis in real-life clinical practice in the Russian Federation (NiSpAR)
Modern Rheumatology Journal ·Т. В. Дубинина, Aleksander M. Lila, E. V. Kvasova, Ekaterina M. Agafonova, Irina A. Andrianova, Larisa Ivanova, D. Yurk, N. Garaeva
20240
18
Survival and lethal outcomes in Orenburg population of patients with systemic lupus erythematosus
Modern Rheumatology Journal ·N. V. Lazareva, О. В. Бугрова, N. E. Artemova, К. А. Нагорнова
20240

About О. В. Бугрова

О. В. Бугрова is a scholar working on Rheumatology, Anatomy, Orthopedics and Sports Medicine, Immunology and Complementary and Manual Therapy, having authored 18 papers that have together received 930 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (9 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Medical and Biological Sciences (3 papers), Psoriasis: Treatment and Pathogenesis (2 papers), Bone and Joint Diseases (2 papers), Systemic Lupus Erythematosus Research (2 papers), Healthcare Systems and Public Health (1 paper) and Bone health and osteoporosis research (1 paper). The work is most often cited by research in Rheumatology (614 citations), Nephrology (74 citations), Hematology (101 citations), Immunology (160 citations) and Cardiology and Cardiovascular Medicine (142 citations). О. В. Бугрова has collaborated with scholars based in Russia, United Kingdom and United States. Frequent co-authors include Andrey P. Rebrov, Tatiana V Korotaeva, Olga B. Nesmeyanova, Tatiana A. Raskina, Ш. Ф. Эрдес, Irina Petrovna Nikishina, Olga Nikolaevna Ivanova, Alexander Smirnov, Tatiana Dubinina and Alexey V. Smirnov. Their work appears in journals such as Journal of the American Heart Association, Kidney International, The Lancet, Terapevticheskii arkhiv and Rheumatology Science and Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.C. HeslingaBreakdown of academic impact, for papers by Alessia MorelliBreakdown of academic impact, for papers by Etsuji SuehisaBreakdown of academic impact, for papers by Emily Wai Lin KunBreakdown of academic impact, for papers by B. BoutièreBreakdown of academic impact, for papers by Deva SitunayakeBreakdown of academic impact, for papers by JP CosynsBreakdown of academic impact, for papers by Francesca BartoliBreakdown of academic impact, for papers by Shinobu WagaBreakdown of academic impact, for papers by Alberto Alonso-Ruiz